tiprankstipranks
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market

Day One Biopharmaceuticals (DAWN) Financial Statements

136 Followers

Day One Biopharmaceuticals Financial Overview

Day One Biopharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.362; its P/E ratio is -6.68; Day One Biopharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 3.65M$ 0.00
Gross Profit---$ 3.65M-
EBIT$ -46.15M$ -45.86M$ -35.23M$ -61.26M$ -39.70M
EBITDA$ -46.05M$ -45.77M$ -35.14M-$ -39.53M
Net Income Common Stockholders$ -46.15M$ -45.86M$ -31.76M$ -58.60M$ -37.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 405.54M$ 442.88M$ 318.18M$ 342.27M$ 374.34M
Total Assets$ 414.18M$ 450.76M$ 323.49M$ 349.06M$ 381.86M
Total Debt$ 514.00K$ 618.00K$ 717.00K$ 813.00K$ 976.00K
Net Debt$ -405.02M$ -442.26M$ -317.46M$ -341.46M$ -373.37M
Total Liabilities$ 24.55M$ 24.70M$ 23.15M$ 349.06M$ 18.79M
Stockholders Equity$ 389.63M$ 426.05M$ 300.42M$ 332.04M$ 363.08M
Cash Flow-
Free Cash Flow$ -37.10M$ -42.58M$ -26.01M$ -35.31M$ -23.22M
Operating Cash Flow$ -37.06M$ -42.43M$ -25.98M$ -35.31M$ -23.21M
Investing Cash Flow$ 88.92M$ 20.27M$ -11.19M$ -2.21M$ -246.85M
Financing Cash Flow$ 115.00K$ 162.10M$ 1.18M$ 1.92M$ 2.05M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

Day One Biopharmaceuticals Debt to Assets

Day One Biopharmaceuticals Cash Flow

Day One Biopharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis